Australia's largest stock trading and investment forum Australia's #1 stock forum

SFI

Click for more information

0.00%

9.0¢ spookfish limited

How are you voting to the takeover?, page-60

First 60 Last

Share
Profile

Follow
substanceonly

46 Posts.

22

02/08/18

17:01

Post #: 34694024
Share

Originally posted by goosmurf ↑

I've held out on SFI thus far because of the cap implications of the Milestone shares.

But now that we know EagleView is interested I got in at 7.6c/share today.

EV is significantly undervaluing SFI. Between Clearlake's recent equity investment and EV already having exclusive rights to SFI's tech in the US, it seems evident that EV's plan is to take SFI global.

NEA has $48.8m ACV just in Australia. EV must be doing north of US$200m in the US just on their old product. The global market must be north of $1bn annually.

And here we have EV bidding $121m. For one of only 2 companies in the world that have the necessary technology.

Of course SFI as a standalone business would not be worth $121m today but between the two tensions I think EV needs SFI more than SFI investors need 8c/share today.

I'd guess that EV would need to raise the bid to something around 12c or more to get this deal over the line.

The downside risk is the deal falls over and I take a 33% haircut. But I'd be willing to hold in that case -- I've held NEA for 8 years -- the technology is solid and EV just validated its importance.

Expand

Agree 110% ...Another 3.2m shares voting no
and I purchased some more in another entity...with another no vote to be registered

SFI Price at posting: 7.6¢ Sentiment: Hold Disclosure: Held
4 Upvote

0 Great analysis

Reply

Top Stories

ASX Market Open: Australian bourse to fall as subdued Wall Street awaits rate cut decision | September 18, 2024

88E

HotCopper users smell capital raising as 88 Energy says "significant update" at Phoenix

HVN

Harvey Norman clocks subdued gains as Echo Law's junk warranty class action kicks off

CXU

Cauldron discovers shallow uranium up to 2km at WA's Yanrey

PAR

FDA hands Paradigm Biopharma guidance to re-jig phase 3 osteo trial – or is it a delay?

There are more pages in this discussion • 32 more messages in this thread...

First 60 Last

Add SFI (ASX) to my watchlist